Evolution of the Average Target: Amplifon

Evolution of the Target Price: Amplifon

Changes in Analyst Recommendations: Amplifon

ce5a.A90XIN0makXfiz1FtYx5mzg9QO9_mIIf2LowwacDqiw.Z6pjYut2DiCo2QkEhcoR71ttKYEcr89YnYoIk-Fk4HRu6XNrghEyFpzoXg~142d6f3f0685f6e58c2d325e19aa7300
03/09 Morgan Stanley Begins Amplifon with Overweight Rating MT
21/08 Intesa Sanpaolo Upgrades Amplifon to Buy, Reduces PT MT
01/08 Amplifon: Profitability beat and improving fundamentals point to a guidance upgrade Alphavalue
31/07 Banca Akros Upgrades Amplifon to Accumulate, Lifts PT MT
27/07 JPMorgan Upgrades Amplifon to Overweight Rating MT
17/07 MedTech facing a three-front squeeze Alphavalue
03/07 Amplifon rallies on the Milan exchange after Equita's buy call AN
19/06 AlphaValue/Baader Europe Upgrades Amplifon to Buy, Lifts PT MT
25/05 Kepler Cheuvreux Upgrades Amplifon to Buy, Boosts PT MT
13/05 Amplifon Price Target Rises as Bernstein Ups Estimates Post Q1 Results; Market-perform Rating Kept MT
06/05 Morningstar Downgrades Amplifon to Hold, Lifts PT MT
06/05 Amplifon: Promising start to 2026 Alphavalue
02/04 BNP Paribas Downgrades Amplifon to Neutral, Cuts PT MT
27/03 Amplifon: Hardship persists Alphavalue
19/03 Jefferies Downgrades Amplifon to Hold Rating, Cuts PT MT
19/03 Barclays Downgrades Amplifon to Equalweight, Cuts PT MT
18/03 Equita SIM Downgrades Amplifon to Hold Rating, Cuts PT MT
17/03 Amplifon shares tumble following external growth operation Zonebourse
17/03 Amplifon: Amplifon is hunting big game Alphavalue
06/03 Amplifon: Q4 miss rattles market's faith in delivering on next year's targets Alphavalue
12/02 Morningstar Kicks Off Amplifon Coverage with Hold Rating MT
08/12 AlphaValue/Baader Europe Cuts Amplifon Price Target, Estimates Amid Ongoing Macro Headwinds MT
06/12 Amplifon target cut amid market slowdown Alphavalue
20/11 RBC Capital Starts Amplifon Coverage with Sector Perform Rating MT
19/11 RBC Initiates Amplifon at Sector Perform, Notes 'Balanced' Risk-Reward Amid Market Weakness MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+18.73%
+18.27%
+20.31%
+6.44%
+28.59%
+9.07%
+28.35%
+10.02%
+10.88%
Average +16.74%
Weighted average by Cap. +17.81%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
11.42EUR
Average target price
13.62EUR
Spread / Average Target
+19.26%
High Price Target
16.70EUR
Spread / Highest target
+46.17%
Low Price Target
11.10EUR
Spread / Lowest Target
-2.84%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA